Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City

AIDS

Volumn 10, Issue 9, 1996, Pages 1009-1015

  Dufour, Annie ^a,b   Alary, Michel ^a,b,c   Poulin, Céline ^c   Allard, Francine ^c   Noël, Lina ^c   Trottier, Germain ^b   Lépine, Debbie ^d   Hankins, Catherine ^e  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Quebec National Public Health Institute   (Canada)

^d LAB CENTRE FOR DISEASE CONTROL   (Canada)

^e Montreal Reg Pub Health Department   (Canada)

Author keywords

HIV; Injecting drug users; Prevalence; Prison

Indexed keywords

ADULT; ARTICLE; CANADA; DRUG ABUSE; FEMALE; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEEDLE; PREVALENCE; PRIORITY JOURNAL; PRISON; PRISONER; SEXUAL INTERCOURSE;

EID: 0030002311     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199610090-00012     Document Type: Article

References (32)

1. Centers for Disease Control: Acquired immune deficiency syndrome (AIDS) in prison inmates - New York, New Jersey. MMWR 1983, 31:700-701.
2. Singleton JA, Perkins CI, Trachtenberg AI, Hughes MJ, Kizer KW, Ascher M: HIV antibody seroprevalence among prisoners entering California correctional system. West J Med 1990, 153:394-399.
3. Harding TW: AIDS in prison. Lancet 1987, ii: 1260-1264.
4. Glass GE, Hausler WJ, Loeffelholz PL, Yesalis CE: Seroprevalence of HIV antibody among individuals entering the Iowa prison system. Am J Public Health 1988, 78:447-449.
5. Andrus JK, Fleming DW, Knox C, et al.: HIV testing in prisoners: is mandatory testing mandatory? Am J Public Health 1989, 79:840-842.
6. Rothon DA, Mathias RG, Schechter MT: Prevalence of HIV infection in provincial prisons in British Columbia, Can Med Assoc J 1994, 151:781-787.
7. Rotily M, Galinier-Pujol A, Obadia Y, et al.: HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons. AIDS 1994, 8:1341-1344.
8. Vlahov D, Brewer TF, Castro KG, et al.: Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991, 265:1129-1132.
9. Weisfuse IB, Greenberg BL, Back SD, et al.: HIV-1 infection among New York City inmates. AIDS 1991, 5:1133-1138.
10. Clavel T, Lecourt JF, Demain A, Rousseau I, Thomas P: HIV seroprevalence and risks factors among female inmates in a French prison. J Acquir Immune Defic Syndr 1992, 5:428-430.
11. Centers for Disease Control: HIV prevention in US correctional system, 1991. JAMA 1992, 268:23-24.
12. Martin V, Bayas JM, Laliga A, et al.: Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. AIDS 1990, 4:1023-1026.
13. Bird AG, Gore SM, Jolliffe DW, Burns SM: Anonymous HIV surveillance in Saughton prison, Edinburgh. AIDS 1992, 6:725-733.
14. Gaughwin MD, Douglas RM, Liew C, et al.: HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS 1991, 5:845-851.
15. Hoxie NJ, Vergeront JM, Frisby HR, Pfrister JR, Golubjatnikov R, Davis JP: HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health 1990, 80:1129-1131.
16. Käll KI, Olin RG: HIV status changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. AIDS 1990, 4:153-157.
17. Serraino D, Franceschi S, Vaccher E, et al.: Illicit use of intravenous drugs, imprisonment and HIV infection in northern Italy [letter]. AIDS 1990, 4:262-264.
18. Hankins C, Gendron S, Handley M, Rouah F, O'Shaughnessy M: HIV-1 infection among incarcerated men - Quebec. Can Dis Wkly Rep 1991, 17:233-235.
19. Ford PM, Alifo A, Connop PJ, Panaro L, Zoutman D: Seroprevalence of HIV-1 in a male medium security penitentiary - Ontario. Can Commun Dis Rep 1994, 20:45-47.
20. Ford PM, White C, Kaufmann H, et al.: Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. Can Med Assoc J 1995, 153:1605-1609.
21. Calzavara L, Major C, Myers T, Schlossberg J: The prevalence of HIV-1 infection among inmates in Ontario, Canada. Can J Public Health 1995, 5:335-339.
22. Meliço-Sylvestre A, Pombo V, Pereira A, Lopes R, Corte-Real R: Seroepidemiological survey of transmissible infections in Portuguese prisoners [letter]. AIDS 1991, 5:780-781.
23. Taylor A, Goldberg D, Emslie J, et al.: Outbreak of HIV infection in a Scottish prison. BMJ 1995, 310:289-292.
24. Gore SM, Bird AG, Burns SM, Goldberg DJ, Ross AJ, Macgregor J: Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ 1995, 310:293-296.
25. Hankins CA, Gendron S, Handley MA, Richard C, Lai Tung MT, O'Shaughnessy M: HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. Am J Public Health 1994, 84:1637-1640.
26. Laboratory Centre tor Disease Control: Proceedings of the Meeting on HIV Infection Among Injection Drug Users in Canada, Montreal [12-13 December 1994]. Ottawa: Health Canada; 1994:9-10.
27. Bird AG, Gore SM, Cameron S, Ross AJ, Goldberg DJ: Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS 1995, 9:801-808.
28. Gleghorn AA, Doherty MC, Vlahov D, et al.: Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr 1994, 7:767-772.
29. Expert Committee on AIDS and Prisons: HIV/AIDS in Prisons [Documentation, February 1994]. Ottawa: Correctional Service Canada; 1994.
30. Hankins C: Confronting HIV infection in prisons. Can Med Assoc J 1994, 151:81-83.
31. Titti F, Rezza G, Verani P, et al.: HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors. J Acquir Immune Defic Syndr 1988, 1:405-411.
32. Solomon L, Astremborski J, Warren D, et al.: Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol 1993, 137:892-898.